Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

Related Articles by Review for PubMed (Select 19193912)

1.

Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Khan A, Grey A, Shoback D.

J Clin Endocrinol Metab. 2009 Feb;94(2):373-81. doi: 10.1210/jc.2008-1762. Review.

PMID:
19193912
2.

Cinacalcet for the treatment of primary hyperparathyroidism.

Dillon ML, Frazee LA.

Am J Ther. 2011 Jul;18(4):313-22. doi: 10.1097/MJT.0b013e3181bdc3d0. Review.

PMID:
20228675
3.

Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism.

Marcocci C, Bollerslev J, Khan AA, Shoback DM.

J Clin Endocrinol Metab. 2014 Oct;99(10):3607-18. doi: 10.1210/jc.2014-1417. Epub 2014 Aug 27.

PMID:
25162668
4.

Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR.

J Clin Endocrinol Metab. 2009 Feb;94(2):351-65. doi: 10.1210/jc.2008-1760. Review.

PMID:
19193910
5.

Management of skeletal health in patients with asymptomatic primary hyperparathyroidism.

Lewiecki EM.

J Clin Densitom. 2010 Oct-Dec;13(4):324-34. doi: 10.1016/j.jocd.2010.06.004. Review.

PMID:
21029971
6.

Medical management of primary hyperparathyroidism.

Khan AA.

J Clin Densitom. 2013 Jan-Mar;16(1):60-3. doi: 10.1016/j.jocd.2012.11.010. Review.

PMID:
23374743
7.

Primary hyperparathyroidism and the skeleton.

Mosekilde L.

Clin Endocrinol (Oxf). 2008 Jul;69(1):1-19. doi: 10.1111/j.1365-2265.2007.03162.x. Epub 2008 Jul 1. Review.

PMID:
18167138
8.

Asymptomatic primary hyperparathyroidism: new issues and new questions--bridging the past with the future.

Bilezikian JP, Potts JT Jr.

J Bone Miner Res. 2002 Nov;17 Suppl 2:N57-67. Review.

PMID:
12412779
9.

Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects.

Duntas LH, Stathatos N.

Endocrine. 2011 Jun;39(3):199-204. doi: 10.1007/s12020-011-9452-7. Epub 2011 Mar 26. Review.

PMID:
21442382
10.

Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, Cusano NE, Dempster D, Lewiecki EM, Liu JM, Minisola S, Rejnmark L, Silva BC, Walker MD, Bilezikian JP.

J Clin Endocrinol Metab. 2014 Oct;99(10):3580-94. doi: 10.1210/jc.2014-1415. Epub 2014 Aug 27.

PMID:
25162667
11.

Update on the use of cinacalcet in the management of primary hyperparathyroidism.

Marcocci C, Cetani F.

J Endocrinol Invest. 2012 Jan;35(1):90-5. doi: 10.3275/8112. Epub 2011 Nov 21. Review.

PMID:
22104762
12.

Mild primary hyperparathyroidism: a literature review.

Applewhite MK, Schneider DF.

Oncologist. 2014 Sep;19(9):919-29. doi: 10.1634/theoncologist.2014-0084. Epub 2014 Jul 25. Review.

PMID:
25063228
13.

Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Eastell R, Arnold A, Brandi ML, Brown EM, D'Amour P, Hanley DA, Rao DS, Rubin MR, Goltzman D, Silverberg SJ, Marx SJ, Peacock M, Mosekilde L, Bouillon R, Lewiecki EM.

J Clin Endocrinol Metab. 2009 Feb;94(2):340-50. doi: 10.1210/jc.2008-1758. Review.

PMID:
19193909
14.

Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.

Dong BJ.

Clin Ther. 2005 Nov;27(11):1725-51. Review.

PMID:
16368445
15.

Medical management of primary hyperparathyroidism with concomitant multiple myeloma.

Fanari Z, Kadikoy H, Haque W, Pacha O, Abdellatif A.

Intern Med. 2010;49(6):581-4. Epub 2010 Mar 15. Review.

16.

New strategies for the treatment of hyperparathyroidism incorporating calcimimetics.

de Francisco AL.

Expert Opin Pharmacother. 2008 Apr;9(5):795-811. doi: 10.1517/14656566.9.5.795. Review.

PMID:
18345956
17.

Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis.

Sankaran S, Gamble G, Bolland M, Reid IR, Grey A.

J Clin Endocrinol Metab. 2010 Apr;95(4):1653-62. doi: 10.1210/jc.2009-2384. Epub 2010 Feb 3. Review.

PMID:
20130069
18.

The role of calcimimetics in the treatment of hyperparathyroidism.

Wüthrich RP, Martin D, Bilezikian JP.

Eur J Clin Invest. 2007 Dec;37(12):915-22. Review.

PMID:
18036025
19.

[Medical treatment for primary hyperparathyroidism].

Sugimoto T.

Clin Calcium. 2005 Dec;15(12):60-5. Review. Japanese.

PMID:
16322675
20.

The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Udelsman R, Åkerström G, Biagini C, Duh QY, Miccoli P, Niederle B, Tonelli F.

J Clin Endocrinol Metab. 2014 Oct;99(10):3595-606. doi: 10.1210/jc.2014-2000. Epub 2014 Aug 27.

PMID:
25162669
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk